The past decade has seen the global reemergence and rapid spread of enterovirus D68 (EV-
D68), a respiratory pathogen that causes severe respiratory illness and paralysis in children …

The SARS-CoV-2 pandemic has highlighted the importance of behavioral drivers in
epidemic dynamics. With the relaxation of mandated nonpharmaceutical interventions …

Summary Enterovirus D68 (EV-D68), first isolated in 1962, emerged in 2014, causing
outbreaks of severe respiratory infections and acute flaccid myelitis. In this systematic …

Abstract Enterovirus D68 (EV-D68) infections are associated with severe respiratory disease
and acute flaccid myelitis (AFM). The European Non-Polio Enterovirus Network (ENPEN) …

After an extended period of low EV-D68 circulation during the COVID-19 pandemic,
surveillance data suggest increased detection of rhinovirus/enterovirus and EV-D68 …

Pathogens of the enterovirus genus, including poliovirus and coxsackieviruses, typically
circulate in the summer months suggesting a possible positive association between warmer …

Non-pharmaceutical interventions (NPIs) and societal behavioural changes during the
COVID-19 pandemic altered not only the spread of SARS-CoV-2, but also the predictable …

Abstract Background Nonpharmaceutical interventions (NPIs) have been implemented to
suppress transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network,
United States, July–November 2018–2020 | MMWR Skip directly to site content Skip directly to …

Background An increase in influenza like illness in children and adolescents at the Johns
Hopkins Health system during summer 2022 was associated with increased positivity for …